Effect of ciprofloxacin on the pharmacokinetics of ropivacaine (Q44334614)

2 December 2017

Effect of ciprofloxacin on the pharmacokinetics of ropivacaine (English)

1 reference

2 December 2017

1 reference

Mika J Jokinen

1

1 reference

2 December 2017

Klaus T Olkkola

series ordinal

2

1 reference

2 December 2017

Jouni Ahonen

series ordinal

3

1 reference

2 December 2017

Pertti J Neuvonen

series ordinal

4

1 reference

2 December 2017

29 January 2003

1 reference

European Journal of Clinical Pharmacology

2 December 2017

1 reference

2 December 2017

58

1 reference

2 December 2017

653-657

1 reference

2 December 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-002-0540-8

2 December 2017

0 references

cites work

Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

The influence of quinolone derivatives on theophylline clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

Lack of metabolic racemisation of ropivacaine, determined by liquid chromatography using a chiral AGP column.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0540-8

The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine.

21 January 2018

1 reference

12 December 2020

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

1 reference

12 December 2020

1 reference

12 December 2020

4-quinolones inhibit biotransformation of caffeine

1 reference

12 December 2020

Acute toxicity of ropivacaine compared with that of bupivacaine.

1 reference

12 December 2020

Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection.

1 reference

12 December 2020

Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.

1 reference

12 December 2020

Metabolism and excretion of ropivacaine in humans.

1 reference

12 December 2020

Studies on sulfation of synthesized metabolites from the local anesthetics ropivacaine and lidocaine using human cloned sulfotransferases

1 reference

12 December 2020

Disposition kinetics of ropivacaine in humans

1 reference

12 December 2020

Pharmacokinetics of ropivacaine and bupivacaine during 21 hours of continuous epidural infusion in healthy male volunteers.

1 reference

12 December 2020

10.1007/S00228-002-0540-8

Identifiers

DOI

1 reference

2 December 2017

1 reference